A new open-source tool is reshaping how engineers design multi-material objects. Charles Wade, a fourth-year PhD student in the Department of Computer Science at CU Boulder, has created a design ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Crowe Cos. purchased the once ...
CAMBRIDGE — The process of artistic creation is inherently mysterious. So, too, in many respects, is mental illness. And when the two converge? In the case of Australian performer Sam Kissajukian, who ...
John Keels CG Auto (JKCG) said this week that it has consistently maintained, and indicated its willingness to subject the select vehicle models (a current dispute with the Customs and the focus of an ...
LAREDO, Tex. (KGNS) - According to the Laredo Police Department, three people were injured after an accident on a busy roadway on Saturday, October 11. LPD said multiple people called, saying that a ...
The Gazette offers audio versions of articles using Instaread. Some words may be mispronounced. Following news last week that Alliant Energy is “deprioritizing” construction of a new natural gas fired ...
Abstract: This paper proposes adaptive distributed detection schemes for terminal-collaborative multiple-input multiple-output (MIMO) systems, in which multiple wireless terminals jointly receive MIMO ...
Aside from its middling battery life, the DualSense is an absolute joy to use – and we can’t wait to see how haptic feedback and adaptive triggers impact future PlayStation 5 games to come. Why you ...
Abstract: Communication imperfections, such as variable sampling periods and packet dropouts induced by insufficient network bandwidth, can degrade the control performance and even jeopardize the ...
A new open-source tool is reshaping how engineers design multi-material objects. Charles Wade, a Ph.D. student in the Department of Computer Science at the University of Colorado Boulder, has created ...
The centerpiece of the deal is orelabrutinib, a BTK inhibitor in late-stage development for multiple sclerosis that Biogen once paid $125 million for but abandoned after less than two years of testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback